What is Maxim Group’s Estimate for Oxbridge Re Q2 Earnings?

Oxbridge Re Holdings Limited (NASDAQ:OXBR) – Maxim Group issued their Q2 2026 earnings per share (EPS) estimates for Oxbridge Re in a note issued to investors on Tuesday, June 16th. Maxim Group analyst A. Klee forecasts that the insurance provider will post earnings of $0.04 per share for the quarter. Maxim Group has a “Buy” rating and a $3.00 price objective on the stock. Maxim Group also issued estimates for Oxbridge Re’s Q3 2026 earnings at ($0.05) EPS, Q4 2026 earnings at ($0.05) EPS, FY2026 earnings at ($0.04) EPS, Q1 2027 earnings at ($0.06) EPS, Q2 2027 earnings at $0.04 EPS, Q3 2027 earnings at ($0.06) EPS, Q4 2027 earnings at ($0.06) EPS and FY2027 earnings at ($0.13) EPS.

Separately, Weiss Ratings cut shares of Oxbridge Re from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, June 3rd. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Oxbridge Re currently has an average rating of “Hold” and an average target price of $3.00.

Oxbridge Re Price Performance

OXBR stock opened at $1.03 on Thursday. The company has a 50 day simple moving average of $0.90 and a 200 day simple moving average of $1.06. The stock has a market cap of $8.34 million, a price-to-earnings ratio of -4.12 and a beta of 2.02. Oxbridge Re has a 1 year low of $0.66 and a 1 year high of $2.86. The company has a debt-to-equity ratio of 0.16, a current ratio of 8.15 and a quick ratio of 8.15.

Oxbridge Re (NASDAQ:OXBR) last posted its earnings results on Saturday, February 14th. The insurance provider reported $0.02 EPS for the quarter. Oxbridge Re had a negative net margin of 76.47% and a negative return on equity of 33.33%. The firm had revenue of $0.58 million during the quarter.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Virtu Financial LLC bought a new stake in Oxbridge Re in the third quarter valued at $32,000. International Assets Investment Management LLC acquired a new stake in shares of Oxbridge Re in the 4th quarter valued at about $39,000. J.W. Cole Advisors Inc. increased its position in Oxbridge Re by 106.1% in the 4th quarter. J.W. Cole Advisors Inc. now owns 68,000 shares of the insurance provider’s stock valued at $90,000 after buying an additional 35,000 shares in the last quarter. Finally, Henrickson Nauta Wealth Advisors Inc. increased its position in Oxbridge Re by 100.0% in the 4th quarter. Henrickson Nauta Wealth Advisors Inc. now owns 137,400 shares of the insurance provider’s stock valued at $185,000 after buying an additional 68,700 shares in the last quarter. 5.64% of the stock is owned by institutional investors.

Oxbridge Re News Roundup

Here are the key news stories impacting Oxbridge Re this week:

• Positive Sentiment: SurancePlus reported annualized returns of 29.3% and 43.4% on its tokenized reinsurance offerings, topping the original target returns and reinforcing the case for the company’s RWA platform. Article Title
• Positive Sentiment: Maxim Group reiterated a Buy rating and $3.00 price target on Oxbridge Re while publishing multiple earnings estimates, which can support the stock by signaling analyst optimism.
• Neutral Sentiment: Maxim’s latest forecasts still call for Oxbridge Re to post losses in several quarters and a full-year loss in FY2026 and FY2027, indicating the business remains unprofitable despite the bullish rating.

Oxbridge Re Company Profile

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.